Literature DB >> 16005363

Identification of a novel WFS1 mutation (AFF344-345ins) in Japanese patients with Wolfram syndrome.

Kouichi Inukai1, Takuya Awata, Kiyoaki Inoue, Susumu Kurihara, Youhei Nakashima, Masaki Watanabe, Takahiro Sawa, Nobuki Takata, Shigehiro Katayama.   

Abstract

Wolfram syndrome (WFS) is an autosomal recessive disorder characterized by early onset diabetes mellitus, progressive optic atrophy, sensorineural deafness and diabetes insipidus. Affected individuals may also have renal tract abnormalities as well as neurogical and psychiatric syndromes. WFS1 encoding a transmembrane protein was identified as the gene responsible for WFS. We report herein a Japanese family, of which two members had this syndrome. In the WFS1 gene of these patients, we identified a novel mutation, a nine nucleotide insertion (AFF344-345ins). In addition, one of these patients had preclinical hypopituitarism, which is an unusual feature of WFS. As only the two family members homozygous for the mutation showed WFS, these data support the notion that this mutation is the cause of WFS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16005363     DOI: 10.1016/j.diabres.2005.01.002

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  2 in total

Review 1.  WS1 gene mutation analysis of Wolfram syndrome in a Chinese patient and a systematic review of literatures.

Authors:  Guang Yu; Man-li Yu; Jia-feng Wang; Cong-rong Gao; Zhong-jin Chen
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

2.  Wolfram syndrome in the Japanese population; molecular analysis of WFS1 gene and characterization of clinical features.

Authors:  Kimie Matsunaga; Katsuya Tanabe; Hiroshi Inoue; Shigeru Okuya; Yasuharu Ohta; Masaru Akiyama; Akihiko Taguchi; Yukari Kora; Naoko Okayama; Yuichiro Yamada; Yasuhiko Wada; Shin Amemiya; Shigetaka Sugihara; Yuzo Nakao; Yoshitomo Oka; Yukio Tanizawa
Journal:  PLoS One       Date:  2014-09-11       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.